By enhancing the expression of lymphangiogenic factors or directly affecting lymphatic endothelial cells, IMP3 could contribute to the expansion of lymphatic networks, providing additional routes for cancer cells to disseminate to regional lymph nodes and beyond. Here, IMP3 is linked to cancer.